148 related articles for article (PubMed ID: 33420364)
41. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
42. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
43. Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion.
Tomas Bort E; Joseph MD; Wang Q; Carter EP; Roth NJ; Gibson J; Samadi A; Kocher HM; Simoncelli S; McCormick PJ; Grose RP
Elife; 2023 Mar; 12():. PubMed ID: 36942939
[TBL] [Abstract][Full Text] [Related]
44. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
45. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
[TBL] [Abstract][Full Text] [Related]
46. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma.
Cong L; Bai Z; Du Y; Cheng Y
Biomed Res Int; 2020; 2020():9210891. PubMed ID: 32185224
[TBL] [Abstract][Full Text] [Related]
47. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma.
Sun YW; Chen YF; Li J; Huo YM; Liu DJ; Hua R; Zhang JF; Liu W; Yang JY; Fu XL; Yan T; Hong J; Cao H
Br J Cancer; 2014 Nov; 111(11):2131-41. PubMed ID: 25314054
[TBL] [Abstract][Full Text] [Related]
48. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
49. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.
Shi HH; Liu HE; Luo XJ
BMB Rep; 2020 Dec; 53(12):658-663. PubMed ID: 33298240
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway.
Yu DL; Zhang T; Wu K; Li Y; Wang J; Chen J; Li XQ; Peng XG; Wang JN; Tan LG
Oncol Rep; 2017 Aug; 38(2):1075-1082. PubMed ID: 28677798
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
[TBL] [Abstract][Full Text] [Related]
52. Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.
Joseph J; Radulovich N; Wang T; Raghavan V; Zhu CQ; Tsao MS
Oncogene; 2020 Jan; 39(2):308-321. PubMed ID: 31477830
[TBL] [Abstract][Full Text] [Related]
53. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
54. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome.
Biondani G; Zeeberg K; Greco MR; Cannone S; Dando I; Dalla Pozza E; Mastrodonato M; Forciniti S; Casavola V; Palmieri M; Reshkin SJ; Cardone RA
FEBS J; 2018 Jun; 285(11):2104-2124. PubMed ID: 29660229
[TBL] [Abstract][Full Text] [Related]
55. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
Zhang J; He DH; Zajac-Kaye M; Hochwald SN
Cell Cycle; 2014; 13(19):3143-9. PubMed ID: 25486573
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X
Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400
[TBL] [Abstract][Full Text] [Related]
57. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.
Xi B; Lai M; Zhang W; Wang F
Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500
[TBL] [Abstract][Full Text] [Related]
59. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma.
Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ
Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285
[TBL] [Abstract][Full Text] [Related]
60. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
